O-12 NCI9673 (part B): A Multi-Institutional ETCTN Randomized Phase II Study of Nivolumab with or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal
ANNALS OF ONCOLOGY(2023)
关键词
Metastatic Anal Cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要